GlaxoSmithKline S.A.E (EGX: BIOC)
Egypt
· Delayed Price · Currency is EGP 42.20
-3.60 (-7.86%)
At close: Oct 15, 2024
GlaxoSmithKline S.A.E Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,600 | 2,240 | 1,823 | 1,812 | 1,993 | 1,704 | Upgrade
|
| Revenue Growth (YoY) | 23.96% | 22.87% | 0.62% | -9.07% | 16.95% | 4.97% | Upgrade
|
| Cost of Revenue | 1,413 | 1,451 | 1,266 | 1,105 | 1,256 | 929.34 | Upgrade
|
| Gross Profit | 1,187 | 789.12 | 557.4 | 706.66 | 737.06 | 774.69 | Upgrade
|
| Selling, General & Admin | 527.77 | 366.27 | 326.91 | 409.16 | 438.5 | 471.07 | Upgrade
|
| Other Operating Expenses | -14.56 | - | 204.15 | 24.56 | 39.18 | 33.42 | Upgrade
|
| Operating Expenses | 580.71 | 347.61 | 542.07 | 464.5 | 534.55 | 507.11 | Upgrade
|
| Operating Income | 606.37 | 441.51 | 15.33 | 242.16 | 202.51 | 267.58 | Upgrade
|
| Interest Expense | -27.75 | -37.96 | -33.5 | -48.67 | -79.91 | -92.65 | Upgrade
|
| Interest & Investment Income | 48.03 | 42.15 | - | 0.26 | 0.54 | 0.79 | Upgrade
|
| Earnings From Equity Investments | -34.41 | -18.12 | 12.15 | -9.21 | -19.49 | 26.97 | Upgrade
|
| Currency Exchange Gain (Loss) | -209.17 | -169.75 | 34.53 | -5.39 | -11.91 | -8.77 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.32 | 7.32 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 390.4 | 265.15 | 28.5 | 179.13 | 91.75 | 193.92 | Upgrade
|
| Impairment of Goodwill | -137.65 | -137.65 | -101 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.74 | 0.17 | 5.94 | 0.24 | 0.15 | 2.35 | Upgrade
|
| Legal Settlements | -7.94 | -7.94 | 3.61 | - | - | 0.93 | Upgrade
|
| Pretax Income | 240.07 | 119.74 | -62.94 | 179.37 | 91.9 | 197.2 | Upgrade
|
| Income Tax Expense | 106.62 | 59.26 | 50.87 | 24.74 | 63.75 | 54.57 | Upgrade
|
| Earnings From Continuing Operations | 133.45 | 60.47 | -113.81 | 154.63 | 28.15 | 142.64 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 849.21 | - | - | - | Upgrade
|
| Net Income to Company | 133.45 | 60.47 | 735.4 | 154.63 | 28.15 | 142.64 | Upgrade
|
| Minority Interest in Earnings | -0.01 | -0.02 | -0.02 | 0.01 | -0.02 | -0.03 | Upgrade
|
| Net Income | 133.44 | 60.46 | 735.38 | 154.64 | 28.13 | 142.61 | Upgrade
|
| Net Income to Common | 133.44 | 60.46 | 735.38 | 154.64 | 28.13 | 142.61 | Upgrade
|
| Net Income Growth | - | -91.78% | 375.56% | 449.70% | -80.27% | 185.69% | Upgrade
|
| Shares Outstanding (Basic) | 84 | 84 | 84 | 84 | 84 | 84 | Upgrade
|
| Shares Outstanding (Diluted) | 84 | 84 | 84 | 84 | 84 | 84 | Upgrade
|
| Shares Change (YoY) | 0.19% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 1.60 | 0.72 | 8.81 | 1.85 | 0.34 | 1.71 | Upgrade
|
| EPS (Diluted) | 1.60 | 0.72 | 8.81 | 1.85 | 0.34 | 1.71 | Upgrade
|
| EPS Growth | - | -91.78% | 375.56% | 449.70% | -80.27% | 185.69% | Upgrade
|
| Free Cash Flow | 69.3 | 225.2 | 987.26 | 156.43 | -54.84 | -195.68 | Upgrade
|
| Free Cash Flow Per Share | 0.83 | 2.70 | 11.82 | 1.87 | -0.66 | -2.34 | Upgrade
|
| Dividend Per Share | 0.750 | 0.750 | - | 0.750 | - | - | Upgrade
|
| Gross Margin | 45.66% | 35.23% | 30.57% | 39.00% | 36.99% | 45.46% | Upgrade
|
| Operating Margin | 23.32% | 19.71% | 0.84% | 13.36% | 10.16% | 15.70% | Upgrade
|
| Profit Margin | 5.13% | 2.70% | 40.33% | 8.53% | 1.41% | 8.37% | Upgrade
|
| Free Cash Flow Margin | 2.67% | 10.05% | 54.15% | 8.63% | -2.75% | -11.48% | Upgrade
|
| EBITDA | 643.08 | 475.56 | 48.6 | 278.32 | 230.91 | 287.89 | Upgrade
|
| EBITDA Margin | 24.73% | 21.23% | 2.67% | 15.36% | 11.59% | 16.89% | Upgrade
|
| D&A For EBITDA | 36.7 | 34.05 | 33.27 | 36.16 | 28.4 | 20.31 | Upgrade
|
| EBIT | 606.37 | 441.51 | 15.33 | 242.16 | 202.51 | 267.58 | Upgrade
|
| EBIT Margin | 23.32% | 19.71% | 0.84% | 13.36% | 10.16% | 15.70% | Upgrade
|
| Effective Tax Rate | 44.41% | 49.50% | - | 13.79% | 69.37% | 27.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.